BioSpace News Archive

Zikani Therapeutics, a company dedicated to leveraging its unique TURBO-ZMTM platform to develop novel ribosome modulating agents (RMAs) for the treatment of rare, nonsense mutation-driven diseases, today announced the close of a $7.5 million Series A-1 financing

PCCA and seven additional medical and pharmacy organizations today asked top government officials to provide more meaningful access to drugs in shortage and not readily available to patients, and provide reimbursement for medications compounded from bulk drug substances when commercially available products are on shortage during the COVID-19 Public Health Emergency (PHE).

Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® announced today that it had received the disbursement of €15 million, corresponding to the first tranche of the loan granted by the European Investment Bank (EIB).

Fresenius Kabi USA, LLC is voluntarily recalling Ketorolac Tromethamine Injection, USP, 60 mg/2 mL, 2 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter.

Braid Health and Carbon Health Also Launch Initiative to Compile and Share COVID-19 Clinical Data with Frontline Healthcare Providers and Data Scientists

As healthcare professionals and first responders have come under increasing strain due to the COVID-19 crisis, Novolex has retooled its manufacturing capabilities and repurposed its supply chains to develop products to protect them.

Sharecare, the digital health company that helps people manage all their health in one place, today announced the launch of an interactive COVID-19 screener – developed in partnership with IPsoft and NTT DATA – to provide the general public with a helpful way to anonymously self-screen for the novel coronavirus

Today The Essentials Group, a business affiliate of The Center for Health Affairs, and Ascend Innovations announced a newly formed business partnership designed for strategic collaboration, innovation and delivery of services and solutions that will impact healthcare and community health across Ohio and beyond.

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2020 will be released before market open on Thursday, April 30, 2020.

Assertio Therapeutics, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced the date of its 2020 Annual Meeting, which will be held as a virtual meeting on May 19, 2020.